Effects of thromboxane A2 on lymphocyte proliferation

This publication has 13 references indexed in Scilit:

• BM 13.177, A SELECTIVE BLOCKER OF PLATELET AND VESSEL WALL THROMBOXANE RECEPTORS, IS ACTIVE IN MAN
  The Lancet, 1984
• Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures.
  The Journal of Experimental Medicine, 1983
• A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2
  Thrombosis Research, 1982
• Endogenous prostaglandin E2 enhances polyclonal immunoglobulin production by tonically inhibiting T suppressor cell activity
  Cellular Immunology, 1982
• SELECTIVE INHIBITION OF THROMBOXANE BIOSYNTHESIS IN HUMAN BLOOD MONONUCLEAR CELLS AND THE EFFECTS ON MITOGEN‐STIMULATED LYMPHOCYTE PROLIFERATION
  British Journal of Pharmacology, 1981
• ADMINISTRATION TO MAN OF UK-37,248-01, A SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASE
  The Lancet, 1981
• In vitro synthesis of prostaglandins and related lipids by populations of human peripheral blood mononuclear cells
  Prostaglandins, 1980
• Regulation of the immune response by prostaglandins
  Clinical Immunology and Immunopathology, 1980
• Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell.
  The Journal of Experimental Medicine, 1977